| 51 |
29412111 | Efficacy of P2Y12 Receptor Blockers After Myocardial Infarction and Genetic Variability of their Metabolic Pathways. | 2019 |
1 |
| 52 |
29890239 | A trial of type 12 purinergic (P2Y12) receptor inhibition with prasugrel identifies a potentially distinct endotype of patients with aspirin-exacerbated respiratory disease. | 2019 Jan |
3 |
| 53 |
30456635 | Ticagrelor Versus Prasugrel for the Treatment of Patients with Type 2 Diabetes Mellitus Following Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis. | 2019 Feb |
1 |
| 54 |
30614864 | De-escalation of anti-platelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a narrative review. | 2019 Jan 20 |
1 |
| 55 |
30641247 | Efficacy and safety of prasugrel therapy for intracranial aneurysms with endovascular treatment: A meta-analysis. | 2019 Feb 15 |
1 |
| 56 |
30685502 | Switching between P2Y12 antagonists - From bench to bedside. | 2019 Apr |
1 |
| 57 |
30689068 | Direct Oral Anticoagulants in Addition to Antiplatelet Therapy for Secondary Prevention after Acute Coronary Syndromes: a Review. | 2019 Jan 28 |
1 |
| 58 |
30723937 | Periprocedural Neuroendovascular Antiplatelet Strategies for Thrombosis Prevention in Clopidogrel-Hyporesponsive Patients. | 2019 Mar |
1 |
| 59 |
30734681 | Structure Activity Relationship of 4-Amino-2-thiopyrimidine Derivatives as Platelet Aggregation Inhibitors. | 2019 |
1 |
| 60 |
30760018 | Clinical Utility of CYP2C19 Genotyping to Guide Antiplatelet Therapy in Patients With an Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention. | 2019 Apr |
1 |
| 61 |
30876967 | Switching between P2Y12 inhibitors: Rationale, methods, and expected consequences. | 2019 May |
1 |
| 62 |
30882670 | Comparison of 1-year clinical outcomes between prasugrel and ticagrelor versus clopidogrel in type 2 diabetes patients with acute myocardial infarction underwent successful percutaneous coronary intervention. | 2019 Mar |
1 |
| 63 |
30922852 | Pharmacology of P2Y receptors. | 2019 Sep |
1 |
| 64 |
31070112 | Safety of Dual-Antiplatelet Therapy After Myocardial Infarction Among Patients With Chronic Kidney Disease. | 2019 May 21 |
1 |
| 65 |
31197411 | Tailored P2Y12 inhibitor treatment in patients undergoing non-urgent PCI-the POPular Risk Score study. | 2019 Sep |
1 |
| 66 |
31198410 | A brief review on resistance to P2Y12 receptor antagonism in coronary artery disease. | 2019 |
1 |
| 67 |
31202949 | Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention. | 2019 Aug 26 |
1 |
| 68 |
31242837 | [Experience with Prasugrel in the Treatment of Patients with Acute Coronary Syndrome]. | 2019 Jun 25 |
2 |
| 69 |
31294325 | Protease-activated receptor-mediated platelet aggregation in acute coronary syndrome patients on potent P2Y12 inhibitors. | 2019 Jul |
2 |
| 70 |
31675507 | In vitro analysis of the effect of contrast agents on the antiaggregant effects of P2Y12 inhibitors. | 2019 Nov |
1 |
| 71 |
28403576 | No Pharmacokinetic Drug-Drug Interaction Between Prasugrel and Vorapaxar Following Multiple-Dose Administration in Healthy Volunteers. | 2018 Feb |
1 |
| 72 |
28982722 | Differences in relative and absolute effectiveness of oral P2Y 12 inhibition in men and women: a meta-analysis and modelling study. | 2018 Apr |
1 |
| 73 |
29146484 | Association Between Ischemic and Bleeding Risk Scores and the Use of New P2Y12 Inhibitors in Patients With Acute Coronary Syndrome. | 2018 Jul |
1 |
| 74 |
29150850 | Comparison of pharmacodynamic effects of ticagrelor vs prasugrel in type 2 diabetes mellitus patients with coronary heart disease. | 2018 Jun |
1 |
| 75 |
29215418 | Switching From Ticagrelor or Prasugrel to Clopidogrel. | 2018 Mar/Apr |
2 |
| 76 |
29224649 | Efficacy and safety of potent platelet P2Y12 receptor inhibitors in elderly versus nonelderly patients with acute coronary syndrome: A systematic review and meta-analysis. | 2018 Jan |
1 |
| 77 |
29336311 | Comparison of the effects of P2Y12 receptor antagonists on platelet function and clinical outcomes in patients undergoing Primary PCI: A substudy of the HEAT-PPCI trial. | 2018 Mar 20 |
1 |
| 78 |
29338536 | P2Y12 receptor inhibitors: an evolution in drug design to prevent arterial thrombosis. | 2018 Mar |
1 |
| 79 |
29456511 | P2Y12 Receptors in Tumorigenesis and Metastasis. | 2018 |
1 |
| 80 |
29534250 | Third-Generation P2Y12 Inhibitors in East Asian Acute Myocardial Infarction Patients: A Nationwide Prospective Multicentre Study. | 2018 Mar |
1 |
| 81 |
29568240 | Differential impact of diabetes mellitus on antiplatelet effects of prasugrel and clopidogrel. | 2018 |
1 |
| 82 |
29782272 | [Duration and Timing of Initiation of Therapy With Platelet P2Y12 Inhibitors in the Treatment of Patients With Acute Coronary Syndrome]. | 2018 Mar |
1 |
| 83 |
29799992 | Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous Coronary Intervention, 2008-2016. | 2018 Jul 1 |
1 |
| 84 |
30103241 | Genotype-Phenotype Association and Impact on Outcomes following Guided De-Escalation of Anti-Platelet Treatment in Acute Coronary Syndrome Patients: The TROPICAL-ACS Genotyping Substudy. | 2018 Sep |
1 |
| 85 |
30196683 | Low-Dose Prasugrel in Patients with Resistance to Clopidogrel for the Treatment of Cerebral Aneurysms. | 2018 Sep |
1 |
| 86 |
30238704 | De-Escalation of P2Y12 Receptor Inhibitor Therapy after Acute Coronary Syndromes in Patients Undergoing Percutaneous Coronary Intervention. | 2018 Oct |
1 |
| 87 |
30478067 | Ticagrelor for Refractory Migraine/Patent Foramen Ovale (TRACTOR): An open-label pilot study. | 2018 Nov 27 |
1 |
| 88 |
30648108 | Effect of Potent P2Y12 Inhibitors on Ventricular Arrhythmias and Cardiac Dysfunction in Coronary Artery Disease: A Systematic Review and Meta-Analysis. | 2018 |
1 |
| 89 |
26124456 | Antithrombotic therapy before, during and after emergency angioplasty for ST elevation myocardial infarction. | 2017 Mar |
1 |
| 90 |
26752652 | Oral Antiplatelet Therapy in Coronary Disease. | 2017 Nov/Dec |
1 |
| 91 |
27488859 | Changes in P2Y12 reaction units after switching treatments from prasugrel to clopidogrel in Japanese patients with acute coronary syndrome followed by elective coronary stenting. | 2017 Oct |
1 |
| 92 |
27617370 | Contemporary Management of ST-Elevation Myocardial Infarction. | 2017 Feb |
1 |
| 93 |
27628008 | Proton Pump Inhibitors in Cardiovascular Disease: Drug Interactions with Antiplatelet Drugs. | 2017 |
1 |
| 94 |
27734075 | Efficacy of prasugrel administration immediately after percutaneous coronary intervention in ST-elevation myocardial infarction. | 2017 Jan 5 |
2 |
| 95 |
27922911 | Meta-analysis of Comparison of the Newer P2Y12 Inhibitors (Oral Preparation or Intravenous) to Clopidogrel in Patients With Acute Coronary Syndrome. | 2017 Mar |
1 |
| 96 |
28045759 | Efficacy and Safety of Novel Oral P2Y12 Receptor Inhibitors in Patients With ST-Segment Elevation Myocardial Infarction Undergoing PCI: A Systematic Review and Meta-Analysis. | 2017 Apr |
1 |
| 97 |
28062136 | P2Y12 receptor inhibition with prasugrel and ticagrelor in STEMI patients after fibrinolytic therapy: Analysis from the SAMPA randomized trial. | 2017 Mar 1 |
2 |
| 98 |
28089137 | A comparison of cangrelor, prasugrel, ticagrelor, and clopidogrel in patients undergoing percutaneous coronary intervention: A network meta-analysis. | 2017 Mar |
1 |
| 99 |
28184261 | Dual antiplatelet therapy and non-cardiac surgery: evolving issues and anesthetic implications. | 2017 Feb |
2 |
| 100 |
28204303 | Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors. | 2017 Oct 1 |
1 |